Sheng, Jianhua |
NCT03784222: Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients |
|
|
| Terminated | 4 | 102 | RoW | Blonanserin, MRI and serum BDNF | Sumitomo Pharma (Suzhou) Co., Ltd. | First Episode Schizophrenia, Social Function, Cognition Function, Blonanserin | 11/22 | 11/22 | | |
NCT04859504: Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia |
|
|
| Completed | N/A | 60 | RoW | transcranial alternating current stimulation (NE Starstim) | Shanghai Mental Health Center | Schizophrenia, Transcranial Alternating Current Stimulations, Negative Symptoms | 07/24 | 07/24 | | |
| Completed | N/A | 45 | RoW | Magpro X100 + Option, ThymatronSystem Ⅳ Electroconvulsive System | Shanghai Mental Health Center | Major Depressive Episode | 02/23 | 05/23 | | |
Hu, Qiang Xue |
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer |
|
|
| Active, not recruiting | 3 | 496 | Europe, US, RoW | Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo, Abiraterone acetate and Prednisone | Jiangsu HengRui Medicine Co., Ltd. | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 12/26 | 12/26 | | |
NCT04859504: Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia |
|
|
| Completed | N/A | 60 | RoW | transcranial alternating current stimulation (NE Starstim) | Shanghai Mental Health Center | Schizophrenia, Transcranial Alternating Current Stimulations, Negative Symptoms | 07/24 | 07/24 | | |
NCT05099692: CHD Patient's Concern on Cardiac Rehabilitation |
|
|
| Recruiting | N/A | 3000 | RoW | filling out the questionnaire | Shenyang Northern Hospital | Coronary Heart Disease, Cardiac Rehabilitation | 12/23 | 12/23 | | |